Przegląd Dermatologiczny

Full text

2/2026 vol. 113
Review article

The Relationship Between Microbiota and Pigmentary Diseases: A Systematic Review

Sarah Seyedyousefi 1
,
Azadeh Zolfaghari 1
,
Fariba Iraji 1
,
Zabihollah Shahmoradi 1

  1. Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Dermatol Rev/Przegl Dermatol 2026, 113, 82–88

DOI: https://doi.org/10.5114/dr.2026.163244
Data publikacji online: 2026/07/31
Article file
The Relationship.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Vinay K., Ankad B.S.: Dermatoscopic features of pigmentary diseases in ethnic skin. Indian Dermatol Online J 2021, 12, 24-33.
  2. Wu H., Niu C., Aisa H.A.: Research progress of small molecules as anti-vitiligo agents. Curr Med Chem 2023. doi: 10.2174/0929867330666230214103054.
  3. Iraji F., Seyedyousefi S., Heidari A.: Serum vitamins and trace elements in vitiligo patients: a systematic review and meta-analysis of observational studies. JEADV Clin Pract 2024. doi: 10.1002/jvc2.432.
  4. Guida S., Puig S., Di Raimondo C., Sallustio F., Mangano E., Stabile G., et al.: Melanocortin-1 receptor (MC1R): a review for dermatologists. Ital J Dermatol Venerol 2024, 159, 285-293.
  5. Zhi-jun L.: Effects of vitamins on melanin metabolism. Guide China Med 2013.
  6. Chen Y., Zhang J.Y., Gao S., Li Y.R., Wu Y.F.: Research progress of microbiome and pathogenesis of vitiligo. Life Res 2021, 4, 13.
  7. Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., et al.: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 2021, 10, 89.
  8. Higgins J.P.T., Morgan R.L., Rooney A.A., Taylor K.W., Thayer K.A., Silva R.A., et al.: A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ Int 2024, 186, 108602.
  9. Ganju P., Nagpal S., Mohammed M.H., Nishal Kumar P., Pandey R., Natarajan V.T., et al.: Microbial community profiling shows dysbiosis in the lesional skin of vitiligo subjects. Sci Rep 2016, 6, 18761.
  10. Ni Q., Ye Z., Wang Y., Chen J., Zhang W., Ma C., et al.: Gut microbial dysbiosis and plasma metabolic profile in individuals with vitiligo. Front Microbiol 2020, 11, 592248.
  11. Dellacecca E.R., Cosgrove C., Mukhatayev Z., Akhtar S., Engelhard V.H., Rademaker A.W., et al.: Antibiotics drive microbial imbalance and vitiligo development in mice. J Invest Dermatol 2020, 140, 676-687.e6.
  12. Lu H., Xu J., Hu Y., Luo H., Chen Y., Xie B., et al.: Differences in the skin microbial community between patients with active and stable vitiligo based on 16S rRNA gene sequencing. Australas J Dermatol 2021, 62, e516-e523.
  13. Bzioueche H., Simonyté Sjödin K., West C.E., Khemis A., Rocchi S., Passeron T., et al.: Analysis of matched skin and gut microbiome of patients with vitiligo reveals deep skin dysbiosis: link with mitochondrial and immune changes. J Invest Dermatol 2021, 141, 2280-2290.
  14. Zanchetta C., Vilanova D., Jarrin C., Scandolera A., Chapuis E., Auriol D., et al.: Bacterial taxa predictive of hyperpigmented skins. Health Sci Rep 2022, 5, e609.
  15. Liu C., He D., Yu A., Deng Y., Wang L., Song Z.: Correlation analysis between gut microbiota characteristics and melasma. Front Microbiol 2022, 13, 1051653.
  16. Ali Y., Belback M.R.: Assessment of lifestyle and microbiome contributions to vitiligo development. J Am Acad Dermatol 2022, 87, AB18.
  17. Luan M., Niu M., Yang P., Han D., Zhang Y., Li W., et al.: Metagenomic sequencing reveals altered gut microbial compositions and gene functions in patients with non-segmental vitiligo. BMC Microbiol 2023, 23, 265.
  18. Wu Q., Cheng P., Shao T., Li Z., Ji Q., Wang L., et al.: Alterations of gut microbiota and gut metabolites in young-adult vitiligo patients. J Eur Acad Dermatol Venereol 2023, 37, e904-e907.
  19. Mao R., Yu Q., Li J.: The causal relationship between gut microbiota and inflammatory dermatoses: a Mendelian randomization study. Front Immunol 2023, 14, 1231848.
  20. Kuroda Y., Yang L., Shibata T., Hayashi M., Araki Y., Nishida M., et al.: High α-diversity of skin microbiome and mycobiome in Japanese patients with vitiligo. J Dermatol Sci 2024, 114, 34-43.
  21. Kim S.R., Jo S.J., Koh S.J., Park H.: Impact of dynamic antibiotic exposure on immune-mediated skin diseases in infants and children: a nationwide population-based cohort study. J Am Acad Dermatol 2024, 91, 562-564.
  22. Touni A.A., Sohn R., Cosgrove C., Shivde R.S., Dellacecca E.R., Abdel-Aziz R.T.A., et al.: Topical antibiotics limit depigmentation in a mouse model of vitiligo. Pigment Cell Melanoma Res 2024. doi: 10.1111/pcmr.13164.
  23. Sekino Y., Yamamoto I., Watanabe M., Kuramochi K., Furuyama Y.: Cyclo(L-Pro-L-Tyr) isolated from the human skin commensal Corynebacterium tuberculostearicum inhibits tyrosinase. Int J Mol Sci 2024, 25, 7365.
  24. Yuan X., Wang L., Meng D., Wu L., Wang X., Zhang D., et al.: The impact of NBUVB on microbial community profiling in the lesional skin of vitiligo subjects. Microb Pathog 2020, 140, 103943.
  25. Piyavatin P., Chaichalotornkul S., Nararatwanchai T., Bumrungpert A., Saiwichai T.: Synbiotics supplement is effective for melasma improvement. J Cosmet Dermatol 2021, 20, 2841-2850.
  26. Yu Y., Lee B., Shin K., Kim K., Lee H.J., Shin J.O., et al.: Association between the skin microbiome and lichen striatus hypopigmentation: Cutibacterium acnes as a potential cause. J Eur Acad Dermatol Venereol 2024, 38, 1776-1782.
  27. Grimes P., Bhawan J., Howell M., Desai S., Coryell E., Einziger M., et al.: Histopathological changes induced by malassezin: a novel natural microbiome indole for treatment of facial hyperpigmentation. J Drugs Dermatol 2022, 21, 141-145.
  28. Park H.A., Seo H., Kim S., Haq A.U., Bae S.H., Lee H.J., et al.: Clinical effect of Pediococcus acidilactici PMC48 on hyperpigmented skin. J Cosmet Dermatol 2024, 23, 215-226.
Copyright: © 2026 Polish Dermatological Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Indeks osobowy
Share
without publication fees
without publication fees
Coverage in
Integrated with
plagiat pl
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications